Long-term results of pancreas transplantation under tacrolimus immunosuppression

Transplantation

Volumn 67, Issue 2, 1999, Pages 266-272

  Jordan, Mark L ^a,b   Shapiro, Ron ^b   Gritsch, H Albin ^b,c   Egidi, Francesca ^b   Khanna, Ajai ^b   Vivas, Carlos A ^b   Scantlebury, Velma P ^b   Fung, John J ^b   Starzl, Thomas E ^b   Corry, Robert J ^b  

^a Division of Urologic Surgery   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; ADULT; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033608090     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901270-00014     Document Type: Article

References (27)

1. Sollinger HW, Knechtle SJ, Reed A, et al. Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 1991; 214: 703.
2. Gruessner RWG, Dunn DL, Tzardis PJ, et al. Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. Transplant Proc 1990; 22: 622.
3. Sutherland DER, Gruessner RWG. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997.
4. Pirsch JD, Miller J, Deierhoi MH, Vincenti F. Filo RS. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression after cadaveric renal transplantation: FK 506 Kidney Transplant Study Group. Transplantation 1997; 63: 977.
5. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing tacrolimus (FK 506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997; 64: 436.
6. Jordan ML, Naraghi R, Shapiro R., et al. Tacrolimus rescue therapy for renal allograft rejection: five-year experience. Transplantation 1997; 63: 223.
7. Fung JT, Starzl TE. FK 506 in solid organ transplantation. Ther Drug Monit 1995; 17: 592.
8. Gruessner RWG, Burke GW, Stratta R., et al. A multicenter analysis of the first experience with FK 506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996; 61: 261.
9. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial of FK 506-based immunosuppression after renal transplantation. Transplantation 1995; 59: 485.
10. Shapiro R, Scantlebury VP, Jordan ML, et al. Tacrolimus in pediatric renal transplantation. Transplantation 1996; 62: 1752.
11. Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK 506 and cyclosporine on short and long-term kidney graft survival. Transplantation 1995; 60: 1384.
12. Gruessner RWG for the Tacrolimus Pancreas Transplant Study Group. Tacrolimus in pancreas transplantation: a multicenter analysis. Clin Transplant 1997; 11: 299.
13. Stratta RJ for the FK/MMF Multi-Center Study Group. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multicenter report. Transplant Proc 1997; 29: 654.
14. Corry RJ, Egidi MF, Shapiro R, et al. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. Transplant Proc. 1998; 30: 521.
15. Sugitani A, Egidi MF, Gritsch HA, Corry RJ. Serum lipase as a marker for pancreatic allograft rejection. Transplant Proc 1998; 30: 645.
16. Shapiro R, Scantlebury VP, Jordan ML, et al. Reversibility of tacrolimus induced post-transplant diabetes: an illustrative case and review of the literature. Transplant Proc 1997; 29: 2737.
17. Jordan ML, Shapiro R, Vivas CA, et al. FK 506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994; 57: 860.
18. Christiansen E, Tibell A, Volund AA, et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997; 82: 2299.
19. Tamura K, Fujimura, T, Tsutsami T, et al. Transcriptional inhibition of insulin by FK 506 and possible involvement of FK 506 binding protein-12 in pancreatic beta-cell. Transplantation 1995; 59: 1606.
20. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson RP. Effects of tacrolimus (FK 506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996; 98: 2786.
21. Papaccio G, Latronico M, Chieffi Baceari G. The immunosuppressant FK 506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin. Cell Tissue Res 1994; 277: 573.
22. Steinmuller TM, Graf KJ, Schleicher J, et al. The effect of FK 506 versus cyclosporine on glucose and lipid metabolism: a randomized trial. Transplantation 1994; 58: 669.
23. Strumph P, Kirsch D, Gooding W, Carroll P. The effect of FK 506 on glycemic response as assessed by the hyperglycemic clamp technique. Transplantation 1995; 60: 147.
24. Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Transplantation 1997; 64: 1995.
25. Hariharan S, Munda R, Cavallo T, et al. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. Transplantation 1996; 61: 1161.
26. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation: a prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996; 224: 440.
27. Gritsch HA, Egidi MF, Sugitani A, et al. Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation. Acta Diabetol 1997; 30: 162.